Related references
Note: Only part of the references are listed.Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
Isabelle Vanden Bempt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer
C. L. Hyun et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy
M. Hofmann et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
HER2 status in early breast cancer: Relevance of cell staining patterns, gene amplification and polysomy 17
Rosalba Torrisi et al.
EUROPEAN JOURNAL OF CANCER (2007)
The complexity of genotype alterations underlying HER2-positive by breast cancer: an explanation for its clinical heterogeneity
Isabelle Vanden Bempt et al.
CURRENT OPINION IN ONCOLOGY (2007)
Protein kinase cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification
Alessandra Magnifico et al.
CANCER RESEARCH (2007)
HER-2, TOP2A and chromosome 17 alterations in breast cancer
Ash Rehber Beser et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
Lissandra Dal Lago et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast - A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study
E Downs-Kelly et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Polysomy 17 in HER-2/neu status elaboration in breast cancer: Effect on daily practice
Y Ma et al.
CLINICAL CANCER RESEARCH (2005)
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
M Salido et al.
BREAST CANCER RESEARCH (2005)
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
P Lal et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma
AD Watters et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
The role of the ubiquitination-proteasome pathway in breast cancer - Ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer
S Lipkowitz
BREAST CANCER RESEARCH (2003)
Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization
F Tsukamoto et al.
CANCER CYTOPATHOLOGY (2001)
Share Paper
